サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1420203

内皮機能不全の北米市場：地域別分析 - 原因別、検査タイプ別、エンドユーザー別、予測（～2028年）

North America Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause, Test Type, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 115 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
内皮機能不全の北米市場：地域別分析 - 原因別、検査タイプ別、エンドユーザー別、予測（～2028年）
出版日: 2023年12月14日
発行: The Insight Partners
ページ情報: 英文 115 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の内皮機能不全の市場規模は、2022年に9億5,183万米ドルに達し、2022～2028年にかけてCAGR 4.6%で成長し、2028年には12億4,730万米ドルに達すると予測されています。

心血管疾患の増加が北米の内皮機能不全市場を後押し

世界保健機関（WHO）によると、心血管疾患（CVD）は世界の主要な死因のひとつであり、毎年3,000万人が脳卒中を経験しています。CVDには、脳血管疾患、冠動脈疾患、リウマチ性心疾患、冠動脈疾患（CAD）などが含まれます。CADはすべての心血管系疾患の中で最も一般的な疾患であり、冠動脈の内皮下腔における脂質と免疫細胞の蓄積、すなわちアテローム性動脈硬化を特徴とします。血管内皮の炎症反応が関与しています。CADはアテローム性動脈硬化による冠動脈内腔の狭窄、攣縮、閉塞に起因する心筋の虚血、低酸素、壊死を特徴とします。世界的に死因の第1位となっています。米国疾病予防管理センター（CDC）によると、米国では6,000万人以上の女性（44％）が何らかの心臓病を患っています。心臓病は米国の女性の死因の第1位であり、年齢に関係なく罹患する可能性があります。2021年には、女性の死因は31万661人、つまり女性の死因のほぼ5人に1人が心臓病でした。

米国心臓協会によると、米国では成人のほぼ半数が何らかのCVDに罹患しています。2035年までに1億3,000万人以上、すなわち米国人口の45.1％がCVDに罹患すると予測されています。したがって、内皮機能不全による心血管疾患の有病率の高さが市場を牽引しています。

北米の内皮機能不全の市場概要

北米の内皮機能不全市場は、米国、カナダ、メキシコの主要3カ国に基づいて分析されます。同地域の市場拡大は、心疾患の罹患率の増加と心臓病学インフォマティクスへの投資の増加に起因しています。米国は、CADの負担増加、確立されたヘルスケアインフラ、先進的な内皮機能不全治療薬やデバイスを開発するための研究開発活動などの要因により、北米の内皮機能不全市場で最大の規模を占めています。

北米の内皮機能不全市場の収益と2028年までの予測（金額）

北米の内皮機能不全市場のセグメンテーション

北米の内皮機能不全市場は、原因、検査タイプ、エンドユーザー、国に区分されます。

原因別では、北米の内皮機能不全市場は高血圧、高コレステロール血症、肥満、糖尿病、ベーチェット病、その他に区分されます。2022年の北米の内皮機能不全市場シェアは、高血圧セグメントが最大を記録しました。

検査タイプに基づき、北米の内皮機能不全市場は侵襲的検査と非侵襲的検査に区分されます。侵襲的検査セグメントは、2022年に北米の内皮機能不全市場シェアを大きく維持しました。非侵襲的検査セグメントはさらに、フロー媒介拡張、末梢動脈トノメトリー（PAT）、静脈閉塞プレチスモグラフィー、循環マーカー、その他に細分化されます。

エンドユーザー別に見ると、北米の内皮機能不全市場は病院、診断センター、クリニック、その他に分類されます。2022年の北米の内皮機能不全市場シェアは病院セグメントが最大でした。

国別に見ると、北米の内皮機能不全市場は米国、カナダ、メキシコに区分されます。米国は2022年に北米の内皮機能不全市場を独占しました。

ZOLL Medical Corp、Lawrence Berkeley National Laboratory、Endothelix Inc、Perimed AB、SMART Medical Ltd、Everist Health Inc、Medizinische Messtechnik GmbHなどは、同地域の内皮機能不全市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 北米の内皮機能不全市場 - 重要な要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の内皮機能不全市場 - 市場情勢

  • 概観
  • PEST分析
    • 北米のPEST分析
  • 専門家の見解

第5章 北米の内皮機能不全市場 - 主要市場力学

  • 市場促進要因
    • 心血管疾患の増加
    • 高コレステロール、糖尿病、肥満の増加
  • 市場抑制要因
    • 内皮機能不全のスクリーニング技術に伴う欠点
  • 市場機会
    • 新規バイオマーカーと治療戦略の利用増加
  • 今後の動向
    • 内皮機能不全を評価するための非侵襲的方法の使用
  • 影響分析

第6章 内皮機能不全市場：北米分析

  • 北米の内皮機能不全の市場収益と予測分析

第7章 北米の内皮機能不全市場分析：原因別

  • 北米の内皮機能不全市場：原因別、2022年・2028年（%）
  • 高血圧
  • 糖尿病
  • 高コレステロール血症
  • ベーチェット病
  • 肥満症
  • その他

第8章 北米の内皮機能不全市場分析：検査タイプ別

  • 北米の内皮機能不全市場：検査タイプ別、2022年・2028年（%）
  • 侵襲的検査
  • 非侵襲的検査

第9章 北米の内皮機能不全市場分析：エンドユーザー別

  • 北米の内皮機能不全市場：エンドユーザー別、2022年・2028年（%）
  • 病院
  • 診断センター
  • 診療所
  • その他

第10章 北米の内皮機能不全市場 - 収益と予測（～2028年）：国別分析

  • 北米

第11章 北米の内皮機能不全市場 - 業界情勢

  • 内皮機能不全市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • ZOLL Medical Corp
  • Lawrence Berkeley National Laboratory
  • Endothelix Inc
  • Perimed AB
  • SMART Medical Ltd
  • Everist Health Inc
  • Medizinische Messtechnik GmbH

第13章 付録

図表

List Of Tables

  • Table 1. Techniques Used in to Assess Endothelial Function
  • Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
  • Table 3. US Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
  • Table 16. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
  • Table 17. Glossary of Terms, Endothelial dysfunction market

List Of Figures

  • Figure 1. North America Endothelial Dysfunction Market Segmentation
  • Figure 2. North America Endothelial Dysfunction Market, by Country
  • Figure 3. North America Endothelial Dysfunction Market Overview
  • Figure 4. Hypertension Account for Largest Share of Cause Segment in North America Endothelial Dysfunction Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. Expert Opinion
  • Figure 8. North America Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
  • Figure 9. North America Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
  • Figure 11. Hypertension: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Diabetes: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Hypercholestrolaemia: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Behcet's disease: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Obesity: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. North America Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
  • Figure 18. Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Non-Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Flow Mediated Dilatory: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Venous Occlusion Plethysmography: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Peripheral Arterial Tonometry (PAT): North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Circulating Markers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. North America Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
  • Figure 26. Hospitals and Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Diagnostics Centers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. North America: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. North America: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 32. US: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Growth Strategies in the Endothelial Dysfunction Market
目次
Product Code: BMIRE00029161

The North America endothelial dysfunction market is expected to grow from US$ 951.83 million in 2022 to US$ 1,247.30 million by 2028. It is estimated to grow at a CAGR of 4.6% from 2022 to 2028.

Increasing Incidences of Cardiovascular Diseases Fuels North America Endothelial Dysfunction Market

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are among the leading causes of death worldwide, and ~30 million people experience a stroke each year. CVDs include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and coronary artery disease (CAD). CAD is the most common disease among all cardiovascular diseases, and it is characterized by the accumulation of lipids and immune cells in the subendothelial space of the coronary arteries or atherosclerosis. It involves the inflammatory response of the vascular endothelium. CAD is characterized by ischemia, hypoxia, or necrosis of the myocardium resulting from narrowing, spasm, or obstruction of the coronary artery lumen by atherosclerosis. It has become the leading cause of death worldwide. According to the Centers for Disease Control and Prevention (CDC), over 60 million women (44%) in the US suffer from some form of heart disease. Heart disease is the leading cause of death among women in the US and can affect women of any age. In 2021, it caused 310,661 deaths among women, i.e., nearly one in five female deaths.

According to the American Heart Association, almost half of all adults in the US suffer from a type of CVD. Over 130 million people, i.e., 45.1% of the US population, are projected to suffer from a type of CVD by 2035. Therefore, the high prevalence of cardiovascular diseases due to endothelial dysfunction drives the market.

North America Endothelial Dysfunction Market Overview

The North American endothelial dysfunction market is analyzed on the basis of three major countries: the US, Canada, and Mexico. The market expansion in the region can be attributed to an increase in the incidence of cardiac diseases and rising investments in cardiology informatics. The US holds the largest size of the endothelial dysfunction market in North America owing to factors such as the increasing burden of CAD, established healthcare infrastructure, and R&D activities undertaken to develop advanced endothelial dysfunction drugs and devices.

North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

North America Endothelial Dysfunction Market Segmentation

The North America endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the North America endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, behcet's disease, and others. The hypertension segment registered the largest North America endothelial dysfunction market share in 2022.

Based on test type, the North America endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger North America endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the North America endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest North America endothelial dysfunction market share in 2022.

Based on country, the North America endothelial dysfunction market is segmented into the US, Canada, and Mexico. The US dominated the North America endothelial dysfunction market in 2022.

ZOLL Medical Corp, Lawrence Berkeley National Laboratory, Endothelix Inc, Perimed AB, SMART Medical Ltd, Everist Health Inc, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America endothelial dysfunction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Endothelial Dysfunction Market - by Cause
    • 1.3.2 North America Endothelial Dysfunction Market - by Test Type
    • 1.3.3 North America Endothelial Dysfunction Market - by End User
    • 1.3.4 North America Endothelial Dysfunction Market - by Country

2. North America Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Endothelial Dysfunction Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 Expert Opinion

5. North America Endothelial Dysfunction Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Cardiovascular Diseases
    • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
  • 5.2 Market Restraints
    • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
  • 5.3 Market Opportunities
    • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
  • 5.4 Future Trends
    • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
  • 5.5 Impact Analysis

6. Endothelial Dysfunction Market - North America Analysis

  • 6.1 North America Endothelial Dysfunction Market Revenue Forecast and Analysis

7. North America Endothelial Dysfunction Market Analysis - by Cause

  • 7.1 Overview
  • 7.2 North America Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
  • 7.3 Hypertension
    • 7.3.1 Overview
    • 7.3.2 Hypertension: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Diabetes: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Hypercholestrolaemia
    • 7.5.1 Overview
    • 7.5.2 Hypercholestrolaemia: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Behcet's Disease
    • 7.6.1 Overview
    • 7.6.2 Behcet's Disease: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Obesity
    • 7.7.1 Overview
    • 7.7.2 Obesity: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. North America Endothelial Dysfunction Market Analysis - by Test Type

  • 8.1 Overview
  • 8.2 North America Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
  • 8.3 Invasive Tests
    • 8.3.1 Overview
    • 8.3.2 Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Invasive Tests
    • 8.4.1 Overview
    • 8.4.2 Non-Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Flow Mediated Dilatory
      • 8.4.3.1 Overview
      • 8.4.3.2 Flow Mediated Dilatory: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Venous Occlusion Plethysmography
      • 8.4.4.1 Overview
      • 8.4.4.2 Venous Occlusion Plethysmography: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.5 Peripheral Arterial Tonometry (PAT)
      • 8.4.5.1 Overview
      • 8.4.5.2 Peripheral Arterial Tonometry (PAT): North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Circulating Markers
      • 8.4.6.1 Overview
      • 8.4.6.2 Circulating Markers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.7 Others
      • 8.4.7.1 Overview
      • 8.4.7.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. North America Endothelial Dysfunction Market Analysis - by End User

  • 9.1 Overview
  • 9.2 North America Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostics Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostics Centers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Clinics
    • 9.5.1 Overview
    • 9.5.2 Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. North America Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 North America: Endothelial Dysfunction Market
    • 10.1.1 Overview
      • 10.1.1.1 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 US: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.1.4 US: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.1.4.1 US: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.5 US: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Canada: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.2.4 Canada: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.2.4.1 Canada: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.5 Canada: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.3 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 Mexico: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.3.4 Mexico: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.3.4.1 Mexico: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.5 Mexico: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. North America Endothelial Dysfunction Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Endothelial Dysfunction Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 ZOLL Medical Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Lawrence Berkeley National Laboratory
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Endothelix Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Perimed AB
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6
    • 12.4.7 Key Developments
  • 12.5 SMART Medical Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Everist Health Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Medizinische Messtechnik GmbH
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms